Prof. E Carvalho, member of our Supervisory Board will coordinate the first nationwide study on Type 2 diabetes in Guinea Bissau

   27.04.2021

Final Resolution for the selection process for an ESR short-term application.

   27.04.2021

Preliminary resolution for a selection process for an ESR short-term application

   20.04.2021

Our ESR2 Doctoral Thesis: Effects of the Second Generation Antipsychotics olanzapine and aripiprazole in beta cell functionality and pancreatic islet plasticity.

   17.12.2020

María Monsalve, coordinator of ITN TREATMENT, took part in the 1st meeting of the network REDOX BIOLOGY AND MEDICINE

   26.11.2020

Ángela M Valverde, Coordinator of ITN-Treatment took part in the Joint Annual Meeting of the Sociedades de Biociencias 2020

   26.11.2020

ESRs of ITN-TREATMENT attended the 11th CIBERDEM ANNUAL MEETING

   10.11.2020

WORD FOOD DAY 2020. Impact of Nutrition on Health. Importance in Pandemic Times

   20.10.2020

Article by M. Monsalve, coordinator of TREATMENT, for SEBBM

   24.09.2020

Second Generation Antipsychotics impact in insulin secretion and beta cell function might mediate prediabetes development

   22.09.2020

Our ESR12 defended her Doctoral Thesis: Evaluation of genetic polymorphisms associated with the metabolic effects of olanzapine and aripiprazole

   28.07.2020

Barbara Kramar ESR11 of ITN TREATMENT attended 4 activities and participated in 2 events

   14.07.2020

ESR 12 of TREATMENT at the World Congress of Psychiatric Genetics, 2019

By ITN TREATMENT    26.11.2019

TREATMENT members at the VIII Foro de Esquizofrenia by CIBERSAM in Madrid

By ITN TREATMENT    24.11.2019

ITN TREATMENT at the Cluster Event on Persolanized Medicine in Madrid.

By ITN TREATMENT    08.11.2019

Our coordinator, Maria Monsalve, on the radio

By ITN TREATMENT    28.10.2019